Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Times Interest Earned: 2023-2025

Historic Times Interest Earned for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to $8.34.

  • BioLineRx's Times Interest Earned rose 201.36% to $8.34 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.13, marking a year-over-year decrease of 85.00%. This contributed to the annual value of $2.24 for FY2024, which is 90.23% down from last year.
  • Latest data reveals that BioLineRx reported Times Interest Earned of $8.34 as of Q2 2025, which was up 46.57% from $5.69 recorded in Q1 2025.
  • In the past 5 years, BioLineRx's Times Interest Earned registered a high of $14.76 during Q3 2023, and its lowest value of -$19.92 during Q4 2023.
  • Over the past 3 years, BioLineRx's median Times Interest Earned value was $5.44 (recorded in 2024), while the average stood at $3.81.
  • Per our database at Business Quant, BioLineRx's Times Interest Earned plummeted by 77.55% in 2024 and then skyrocketed by 201.36% in 2025.
  • Over the past 3 years, BioLineRx's Times Interest Earned (Quarterly) stood at -$19.92 in 2023, then surged by 104.96% to $0.99 in 2024, then soared by 201.36% to $8.34 in 2025.
  • Its last three reported values are $8.34 in Q2 2025, $5.69 for Q1 2025, and $0.99 during Q4 2024.